Table 2

Cox analysis of variables predicting progression to dialysis in the testing cohort (Italian cohort, n = 461)

VariableHR (95% CI)P
Univariate analysis   
 Age, y 1.00 (0.98-1.03) .879 
 Male gender 0.73 (0.46-1.16) .190 
 Heart involvement 1.07 (0.65-1.73) .779 
 Cardiac stage III 1.21 (0.69-2.15) .505 
 Liver involvement 1.11 (0.60-2.07) .737 
 Proteinuria, g/24 h 1.11 (1.07-1.15) <.001 
 Proteinuria >5 g/24 h 3.67 (2.05-6.57) <.001 
 eGFR, mL/min per 1.73m2 0.96 (0.95-0.97) <.001 
 eGFR <50 mL/min per 1.73 m2 6.96 (4.15-11.68) <.001 
 Serum albumin, g/L 0.44 (0.29-0.79) .025 
 Serum albumin <30 g/L 4.20 (0.91-19.29) .067 
 dFLC 1.00 (0.99-1.01) .846 
 dFLC >160 ng/L 1.00 (0.62-1.62) .999 
Multivariate model including continuous variables   
 Proteinuria, g/24 h 1.08 (1.03-1.12) <.001 
 eGFR, mL/min per 1.73 m2 0.96 (0.95-0.97) <.001 
 Serum albumin, g/L 1.52 (0.64-6.85) .186 
Multivariate model including dichotomous variables   
 Proteinuria >5 g/24 h 3.91 (2.18-7.00) <.001 
 eGFR <50 mL/min per 1.73 m2 7.24 (4.31-12.15) <.001 
 Serum albumin <30 g/L 1.37 (0.74-8.56) .214 
VariableHR (95% CI)P
Univariate analysis   
 Age, y 1.00 (0.98-1.03) .879 
 Male gender 0.73 (0.46-1.16) .190 
 Heart involvement 1.07 (0.65-1.73) .779 
 Cardiac stage III 1.21 (0.69-2.15) .505 
 Liver involvement 1.11 (0.60-2.07) .737 
 Proteinuria, g/24 h 1.11 (1.07-1.15) <.001 
 Proteinuria >5 g/24 h 3.67 (2.05-6.57) <.001 
 eGFR, mL/min per 1.73m2 0.96 (0.95-0.97) <.001 
 eGFR <50 mL/min per 1.73 m2 6.96 (4.15-11.68) <.001 
 Serum albumin, g/L 0.44 (0.29-0.79) .025 
 Serum albumin <30 g/L 4.20 (0.91-19.29) .067 
 dFLC 1.00 (0.99-1.01) .846 
 dFLC >160 ng/L 1.00 (0.62-1.62) .999 
Multivariate model including continuous variables   
 Proteinuria, g/24 h 1.08 (1.03-1.12) <.001 
 eGFR, mL/min per 1.73 m2 0.96 (0.95-0.97) <.001 
 Serum albumin, g/L 1.52 (0.64-6.85) .186 
Multivariate model including dichotomous variables   
 Proteinuria >5 g/24 h 3.91 (2.18-7.00) <.001 
 eGFR <50 mL/min per 1.73 m2 7.24 (4.31-12.15) <.001 
 Serum albumin <30 g/L 1.37 (0.74-8.56) .214 

dFLC, difference between involved (amyloidogenic) and uninvolved free light chain.

or Create an Account

Close Modal
Close Modal